Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs TJX Companies Inc (TJX) Price & Performance

GE HealthCare Technologies Inc. Common StockTrade
TJX Companies IncTrade

Price performance (Past 24H)

Key statistics

GE HealthCare Technologies Inc. Common Stock vs TJX Companies Inc — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B), while TJX Companies Inc trades at $143.02 (market cap $155.64B). The key difference: TJX Companies Inc is far larger — about 5× GE HealthCare Technologies Inc. Common Stock's market cap, and TJX Companies Inc pays the higher dividend (1.36%). Which is the better fit depends on your goals.

GEHCTJX
Market Cap
$31.07B$155.64B
Volume
3,443,0207,499,607
Sector
HealthConsumer Cyclical
52-Week High
$88.16$168.41
52-Week Low
$59.48$122.84
Enterprise Value
$39.53B$163.95B
Dividend Yield
0.23%1.36%
Typical Hold Time
—97 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GE HealthCare Technologies Inc. Common Stock

GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.

The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.

TJX Companies Inc

TJX trades at $142.80, up 0.62% today, with a bullish technical signal and strong earnings beats in recent quarters. Revenue grew to $56.36B in 2025, with net income of $4.86B and a high ROE of 62.17%. The stock is near its pivot point of $141, with resistance at $143 and support at $139. Analysts are overwhelmingly positive, with an 84.9% buy rating and a consensus price target of $174.15.

Outlook remains positive due to consistent earnings outperformance and projected revenue growth to $62.4B in 2026. Risks include high valuation multiples (P/E 26.2) and competitive pressures in off-price retail. Upside potential is supported by Wall Street optimism and strong cash flow trends.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GEHC

No sentiment data available yet.

TJX
37% Buy63% Sell
Avg holding period · 97 Days

Top news

Latest headlines on both assets

About GE HealthCare Technologies Inc. Common Stock

GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.

Read more on GEHC →

About TJX Companies Inc

TJX is a leading off-price retailer of apparel, home fashions, and other merchandise. It sells a variety of branded goods, opportunistically buying inventory from a network of over 21,000 vendors worldwide. TJX targets undercutting conventional retailers' regular prices by 20%-60%, capitalizing on a flexible merchandising network, relatively low-frills stores, and a treasure-hunt shopping experience to drive margins and inventory turnover. TJX derived 79% of fiscal 2022 revenue from the United States, with 11% from Europe (mostly the United Kingdom and Germany), 9% from Canada, and the remainder from Australia. The company operated 4,689 stores at the end of fiscal 2022 under the T.J. Maxx, T.K. Maxx, Marshalls, HomeGoods, Winners, Homesense, Winners, and Sierra banners.

Read more on TJX →